Production (Stage)
Thermo Fisher Scientific Inc.
TMO
$393.66
-$6.82-1.70%
NYSE
| 03/29/2025 | 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.51B | 1.83B | 1.63B | 1.55B | 1.33B |
| Total Depreciation and Amortization | 705.00M | 747.00M | 734.00M | 791.00M | 836.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -64.00M | 119.00M | -228.00M | -162.00M | -126.00M |
| Change in Net Operating Assets | -1.43B | 594.00M | 30.00M | -216.00M | -787.00M |
| Cash from Operations | 723.00M | 3.29B | 2.17B | 1.96B | 1.25B |
| Capital Expenditure | -362.00M | -480.00M | -272.00M | -301.00M | -347.00M |
| Sale of Property, Plant, and Equipment | 12.00M | 17.00M | 20.00M | 16.00M | 4.00M |
| Cash Acquisitions | -- | 0.00 | -3.13B | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -177.00M | 483.00M | -194.00M | 32.00M | -1.69B |
| Cash from Investing | -527.00M | 20.00M | -3.58B | -253.00M | -2.03B |
| Total Debt Issued | 2.84B | 0.00 | 0.00 | -1.00M | 1.21B |
| Total Debt Repaid | -838.00M | -2.50B | -1.11B | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -2.00B | -1.00B | 0.00 | 0.00 | -3.00B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -149.00M | -149.00M | -150.00M | -149.00M | -135.00M |
| Other Financing Activities | 45.00M | -17.00M | 67.00M | 35.00M | 109.00M |
| Cash from Financing | -102.00M | -3.67B | -1.19B | -115.00M | -1.82B |
| Foreign Exchange rate Adjustments | 37.00M | -273.00M | 175.00M | -15.00M | 22.00M |
| Miscellaneous Cash Flow Adjustments | 1.00M | -1.00M | 0.00 | 1.00M | -- |
| Net Change in Cash | 132.00M | -630.00M | -2.43B | 1.58B | -2.58B |